Robert A H Scott
Overview
Explore the profile of Robert A H Scott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rasool S, Kaushik M, Chaudhary R, Blachford K, Berry M, Scott R, et al.
Graefes Arch Clin Exp Ophthalmol
. 2022 Jan;
260(7):2141-2147.
PMID: 35080648
Purpose: Assess the relationship between photoreceptor degeneration and visual function after retinal reattachment surgery (RRS) in a prospective cohort. Methods: Patients with rhegmatogenous retinal detachment (RRD) were reviewed before and...
2.
Chaudhary R, Scott R, Wallace G, Berry M, Logan A, Blanch R
Transl Vis Sci Technol
. 2020 Aug;
9(3):23.
PMID: 32742753
Purpose: Proliferative vitreoretinopathy (PVR) occurs in 5%-10% of rhegmatogenous retinal detachment cases and is the principle cause for failure of retinal reattachment surgery. Although there are a number of surgical...
3.
Ahmed Z, Morgan-Warren P, Berry M, Scott R, Logan A
Cells
. 2019 Aug;
8(9).
PMID: 31443508
There are contradictory reports on the role of the serine/threonine kinase isoform glycogen synthase kinase-3β (GSK3β) after injury to the central nervous system (CNS). Some report that GSK3 activity promotes...
4.
Begum G, ONeill J, Chaudhary R, Blachford K, Snead D, Berry M, et al.
Invest Ophthalmol Vis Sci
. 2018 Oct;
59(12):4929-4936.
PMID: 30347087
Purpose: To determine if vitreous levels of the pro-fibrotic cytokine transforming growth factor beta2 (TGF-β2) and its opposing regulator decorin predict subsequent proliferative vitreoretinopathy (PVR) development in patients with rhegmatogenous...
5.
de Cogan F, Hill L, Lynch A, Morgan-Warren P, Lechner J, Berwick M, et al.
Invest Ophthalmol Vis Sci
. 2017 May;
58(5):2578-2590.
PMID: 28494491
Purpose: To evaluate the efficacy of anti-VEGF agents for treating choroidal neovascularization (CNV) when delivered topically using novel cell-penetrating peptides (CPPs) compared with delivery by intravitreal (ivit) injection. Methods: CPP...
6.
Townsend L, Williams R, Anuforom O, Berwick M, Halstead F, Hughes E, et al.
J R Soc Interface
. 2017 Jan;
14(126).
PMID: 28077764
The interface between implanted devices and their host tissue is complex and is often optimized for maximal integration and cell adhesion. However, this also gives a surface suitable for bacterial...
7.
Morgan-Warren P, ONeill J, de Cogan F, Spivak I, Ashush H, Kalinski H, et al.
Invest Ophthalmol Vis Sci
. 2016 Feb;
57(2):429-43.
PMID: 26848882
Purpose: To investigate, using in vivo and in vitro models, retinal ganglion cell (RGC) neuroprotective and axon regenerative effects and underlying mechanisms of siRTP801, a translatable small-interfering RNA (siRNA) targeting...
8.
Banerjee P, Xing W, Bunce C, Woodcock M, Chandra A, Scott R, et al.
Br J Ophthalmol
. 2015 Nov;
100(7):949-955.
PMID: 26546051
Purpose: To investigate the feasibility of conducting a randomised controlled trial in patients undergoing pars plana vitrectomy surgery following open globe trauma (OGT). Additionally, to investigate the treatment effect and...
9.
Hill L, Mead B, Blanch R, Ahmed Z, de Cogan F, Morgan-Warren P, et al.
Invest Ophthalmol Vis Sci
. 2015 Jun;
56(6):3743-57.
PMID: 26066743
Purpose: To investigate whether Decorin, a matrikine that regulates extracellular matrix (ECM) deposition, can reverse established trabecular meshwork (TM) fibrosis, lower IOP, and reduce progressive retinal ganglion cell (RGC) death...
10.
Kelly M, Williams R, Aojula A, ONeill J, Trzinscka Z, Grover L, et al.
Mater Sci Eng C Mater Biol Appl
. 2015 Jun;
54:84-93.
PMID: 26046271
Current processes for coating titanium implants with ceramics involve very high energy techniques with associated high cost and disadvantages such as heterogeneity of the coatings, phase transformations and inability to...